Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Zhenge Biotech
company
About
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $100M
- Industries
- Biotechnology,Manufacturing,Pharmaceutical
- Founded date
- Nov 7, 2017
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$100M ¥100M
Zhenge Biotech has raised a total of
$100M ¥100M
in funding over 2 rounds. Their latest funding was raised on
Aug 18, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 18, 2022 | Series C | ¥100M | 1 | — | — | Detail |
| Jan 11, 2022 | Series C | $100M | 2 |
Sofina
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Zhenge Biotech is funded by 3 investors.
Sofina
and Sinopharm-CICC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sofina
|
Yes | Series C |
|
|
— | Series C |
Junxin Yingtai Investment
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
